STAT3 and ovarian carcinoma: This is evidenced by PT reversing Osimertinib-induced STAT3 activation in lung cancer [59], PT inducing cell cycle arrest in gemcitabine-resistant pancreatic cancer cells [56], PT demonstrating synergistic efficacy with cisplatin in ovarian cancer cells [50], PT induction of apoptosis in cisplatin-resistance oral cancer cells [65], and PT showing an additive effect with tamoxifen in breast cancer cells [38].